Published April 2021 | Version v1
Journal article

Natural products in the reprogramming of cancer epigenetics

  • 1. Department of Biotechnology, Faculty of Natural Sciences, Jamia Millia Islamia, New Delhi, 110025 (India)

Description

Highlights: • Cancer epigenetic mechanisms provide significant insights into cancer progression. • Aberrant epigenetic processes are reversible in nature and holds great prospect as anti- cancer therapy. • Natural products are evidenced to play noteworthy role as epi-drugs. • Resveratrol, Quercetin, Genistein among other phytochemicals differentially modulates key epigenetic enzymes. • Dietary epigenetic regulators can maximize clinical benefits to patients, hence expanding cancer management prospects. Owing to the technological advancements, including next generation sequencing, the significance of deregulated epigenetic mechanisms in cancer initiation, progression and treatment has become evident. The accumulating knowledge relating to the epigenetic markers viz. DNA methylation, Histone modifications and non-coding RNAs make them one of the most interesting candidates for developing anti-cancer therapies. The reversibility of deregulated epigenetic mechanisms through environmental and dietary factors opens numerous avenues in the field of chemoprevention and drug development. Recent studies have proven that plant-derived natural products encompass a great potential in targeting epigenetic signatures in cancer and numerous natural products are being explored for their possibility to be considered as "epi-drug". This review intends to highlight the major aberrant epigenetic mechanisms and summarizes the essential functions of natural products like Resveratrol, Quercetin, Genistein, EGCG, Curcumin, Sulforaphane, Apigenin, Parthenolide and Berberine in modulating these aberrations. This knowledge along with the challenges and limitations in this field has potential and wider implications in developing novel and successful therapeutic strategies. The increased focus in the area will possibly provide a better understanding for the development of dietary supplements and/or drugs either alone or in combination. The interaction of epigenetics with different hallmarks of cancer and how natural products can be utilized to target them will also be interesting in the future therapeutic approaches.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.taap.2021.115467

Additional details

Identifiers

DOI
10.1016/j.taap.2021.115467;
PII
S0041008X21000740;

Publishing Information

Journal Title
Toxicology and Applied Pharmacology
Journal Volume
417
Journal Page Range
vp.
ISSN
0041-008X
CODEN
TXAPA9

Optional Information

Copyright
Copyright (c) 2021 Elsevier Inc. All rights reserved.